Localization of Fas and Fas ligand in bone marrow cells demonstrating myelodysplasia

Leukemia
M KitagawaR Kamiyama

Abstract

Frequent apoptosis in the bone marrow of patients with myelodysplastic syndromes (MDS) was demonstrated on frozen sections using the terminal deoxytransferase (TdT)-mediated dUTP nick end labeling (TUNEL) method. The overall mean percentage of TUNEL-positive cells was about 17% in the bone marrow of MDS, while bone marrow from control cases exhibited a mean of 3.4% (P < 0.001). To elucidate the mechanism of apoptosis in bone marrow cells of MDS, the expression of Fas antigen and Fas ligand (FasL) was examined by RT-PCR and immunohistochemistry. All MDS cases showed expression of Fas mRNA (12/12) and most exhibited an expression of FasL mRNA (10/12) by RT-PCR. Basically, control cases did not show positive signals for Fas and FasL mRNA, however, a very weak band was detected in three cases (3/10) for Fas and in one case (1/10) for FasL mRNA by RT-PCR. Immunohistochemical examination revealed positive staining for Fas (11/12) and FasL (12/12) in the bone marrow of MDS, while all the bone marrow samples from control cases were negative for anti-Fas (0/15) and for anti-FasL (0/15) antibody. Double staining clarified that TUNEL-positive apoptotic cells expressed Fas antigen on the cell surface, although not all Fas-positive cells we...Continue Reading

Citations

Aug 16, 2001·International Journal of Hematology·Jane E Parker, Ghulam J Mufti
Dec 4, 2004·Cancer Immunology, Immunotherapy : CII·Masanobu KitagawaKatsuiku Hirokawa
Sep 4, 1999·Leukemia Research·Y Yoshida, G J Mufti
Oct 24, 2001·Experimental Gerontology·K Hirokawa, S Goto
Jun 21, 2005·Nature Reviews. Cancer·Jerry L Spivak
Aug 8, 2006·Oncogene·M FontenayE Solary
Oct 24, 2001·Journal of Hematotherapy & Stem Cell Research·A OdaK Sawada
Feb 25, 2000·Current Opinion in Oncology·R Dansey
Mar 14, 2000·Medical Oncology·A A van de Loosdrecht, E Vellenga
Nov 21, 2012·Expert Opinion on Emerging Drugs·Pearlie K Epling-BurnetteAlan F List
Nov 5, 2013·Critical Reviews in Oncology/hematology·Heidrun KarlicMichael Pfeilstöcker
Nov 26, 2011·Experimental and Molecular Pathology·Shiho SuzukiMasanobu Kitagawa
Apr 3, 2010·Hematology/oncology Clinics of North America·Elaine M Sloand, A J Barrett
Jan 9, 2008·Seminars in Hematology·Elaine M Sloand, Katayoun Rezvani
Nov 3, 2007·Experimental Hematology·Daniella B Kerbauy, H Joachim Deeg
Mar 10, 2005·British Journal of Haematology·H A PapadakiG D Eliopoulos
Feb 24, 2005·American Journal of Hematology·Yasunori NakagawaMasanobu Kitagawa
Oct 12, 2004·European Journal of Clinical Investigation·M VoulgarelisA G Tzioufas
Sep 24, 2004·Leukemia Research·Kouhei YamamotoMasanobu Kitagawa
May 6, 2004·Experimental and Molecular Pathology·Tetsuo NemotoMorio Koike

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis